Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers

Publisher: John Wiley & Sons Inc

E-ISSN: 1743-7563|14|1|52-60

ISSN: 1743-7555

Source: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol.14, Iss.1, 2018-02, pp. : 52-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract